Special Issue "Study of Nanoparticles for Photodynamic Therapy and Imaging"
Deadline for manuscript submissions: closed (15 February 2023) | Viewed by 18415
Photodynamic therapy has long been applied to cancer and non-cancer treatment owing to the numerous breakthroughs and unique advantages, including invasiveness, the opportunity to control therapy in one session, and real-time regime. However, PDT has several limitations, such as selectivity, phototoxic reactions, subcellular and organelle targeting, etc. Nanotechnology has made a significant contribution to PDT, enabling achievement-targeted methods increasing the selectivity of PDT.
Current challenges in biomedical visualization remain for fast and detailed imaging of tissue microstructures and lesion characterization. Nanotechnology offers the possibility to develop nontoxic contrast agents with a longer circulation time and better visualization quality. Promising to greatly benefit clinical practice, nanoparticle-based contrast agents employed in most common biomedical imaging modalities, addressing their structure-related features, advantages, and limitations are of interest for the present Special Issue.
This issue focuses on the design, synthesis, characterization, and application of nanoparticles of the broad spectrum for photodynamic therapy (PDT), fluorescence diagnosis (FD), and imaging. A better understanding of novel concepts in these fields will be useful for improving photodynamic effectiveness and imaging strategies and limiting side effects to normal tissues. We believe that continuous advances in the use of nanomaterials will enhance future development in the treatment and diagnosis of oncological and other diseases.
I hope you will join us and contribute to the success of this Special Issue by submitting the latest and unique results of your research in this interesting field.
Prof. Dr. Victor Loschenov
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- photodynamic therapy
- fluorescence diagnosis
- biomedical imaging
- drug delivery